Back to Insider Trading View Full Company Profile

BNTC

HEALTHY

Benitec Biopharma Inc.

CIK: 0001808898

Strong Buy (90% confidence)

Last activity: Dec 29, 2025

Financial Metrics

As of Jun 30, 2025 (10-K)

Net Income -$37.92M
Total Cash $19.77M
Current Ratio 54.67

Insider Roster (1 total, 1 active)

Insider Buys Sells Net Value Holdings
SUVRETTA CAPITAL MANAGEMENT, LLC
OTHER
12 0 $2.44M
9,700,195 shares
$130.37M

Recent Transactions

BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

65,800 shares @ $13.44

$884K

Dec 29, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

11,587 shares @ $13.44

$156K

Dec 29, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

14,320 shares @ $13.10

$188K

Dec 26, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

2,516 shares @ $13.10

$33K

Dec 26, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

42,600 shares @ $12.85

$547K

Dec 23, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

7,400 shares @ $12.85

$95K

Dec 23, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

16,650 shares @ $12.08

$201K

Dec 22, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

2,892 shares @ $12.08

$35K

Dec 22, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

13,950 shares @ $11.48

$160K

Dec 19, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

2,434 shares @ $11.48

$28K

Dec 19, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

8,700 shares @ $11.24

$98K

Dec 18, 2025

Conviction: | View SEC Filing →
BUY SUVRETTA CAPITAL MANAGEMENT, LLC (OTHER)

1,515 shares @ $11.24

$17K

Dec 18, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.